Combined or single analysis assays of identified tumor markers, including carcinoembryonic antigen (CEA), carbohydrate antigen (CA 19.9), and tumor-associated glycoprotein-72 have been used to detect the transformation of cancer cells for colon cancer diagnosis [37,38,39]. This evidence concerns the gene CEACAM5 and malignant colon neoplasm.